DGNOF — Diagnos Inc.
—
OTC ·
Unknown ·
Unknown ·
CIK 1790693 ·
Last close
$0.33
Market Cap
—
52W High
$0.38
52W Low
$0.13
ADV30
105,697
Next earnings
2026-10-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 15,711 | 1,144,830 | -1,138,304 | -1,184,461 | 2,390,530 | 310,012 | 1,703,633 |
| Dec 2025 | 15,206 | -401,965 | -1,067,631 | -1,161,114 | 3,903,839 | 394,926 | 2,407,925 |
| Sep 2025 | 15,159 | -360,421 | -990,301 | -1,096,342 | 1,172,191 | 490,593 | 2,709,543 |
| Jun 2025 | 19,402 | -372,430 | -1,033,416 | -1,113,282 | 2,053,009 | 118,251 | 2,854,743 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-3,753,516
Investing CF
$1,561,896
Financing CF
$2,412,255
CapEx
$-11,061
Dividends Paid
$0
Buybacks
—
EPS Diluted TTM
$-0.04
As of
2026-07-19
Balance + Analyst (yfinance extras)
Retained Earnings
$-59,488,590
Inventory
—
Receivables
$194,862
ST Investments
$1,616,779
EBIT TTM
$-4,166,658
Pretax Income TTM
$-4,555,199
Interest Exp TTM
$388,541
Analysts
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 65,478 | -4,249,927 | -4,555,199 | 2,390,530 | 1,703,633 | 686,897 | -3,753,516 |
| Mar 2025 | 103,797 | -3,811,093 | -4,286,449 | 3,636,104 | 3,402,994 | 233,110 | -3,637,452 |
| Mar 2024 | 170,158 | -2,590,707 | -3,120,582 | 663,787 | 3,715,635 | -3,051,848 | -2,147,432 |
| Mar 2023 | 485,749 | -2,221,672 | -2,480,816 | 823,031 | 2,771,238 | -1,948,207 | -1,883,811 |
| Mar 2022 | — | — | — | — | — | — | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BRRN | Bryn Inc. | $945.00B | $2100.00 | — |
| KLAC | KLA CORP | $270.31B | $206.89 | — |
| TMO | THERMO FISHER SCIENTIFIC INC. | $242.11B | $654.80 | — |
| IBM | INTERNATIONAL BUSINESS MACHINES CORP | $209.76B | $222.64 | — |
| DHR | DANAHER CORP /DE/ | $150.48B | $214.06 | — |
News headlines (Yahoo Finance, 1h cache)
DIAGNOS Advances Regulatory Strategy with US FDA Submission for CARA System
2026-09-28 15:56 · Yahoo
Presenting on Emerging Growth Conference 96 Day 1 on September 23; Register to live stream
2026-09-22 11:00 · Yahoo
DIAGNOS to Hold its Annual General Meeting of Shareholders on September 30, 2026
2026-09-14 16:41 · Yahoo
DIAGNOS Receives Saudi FDA Medical Device License for CARA System, Bringing AI-Assisted Retinal Image Analysis to Saudi Arabia
2026-08-13 18:21 · Yahoo
DIAGNOS Receives Health Canada Medical Device Licence for CARA System, Bringing AI-Assisted Retinal Image Analysis to Canadian Optometrists
2026-07-27 19:20 · Yahoo
Presenting on Emerging Growth Conference 94 Day 1 on July 15; Register to live stream
2026-07-14 11:00 · Yahoo
DIAGNOS to Extend the Exercise Period of Stock Warrants
2026-07-07 16:38 · Yahoo
DIAGNOS Announces Shares for Debt Settlement
2026-06-18 16:00 · Yahoo
DIAGNOS Submits Modified and Updated Health Canada Licence Application for CARA System Platform
2026-06-16 13:15 · Yahoo
DIAGNOS Announces Grant of Stock Options and Adoption of Semi-Annual Reporting
2026-06-12 19:50 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.